Operational Efficiencies Expected to Generate Approximately US$81 Million Annual Pre-Tax Cost-Saving Synergies for New Tilray Within Eighteen Months
Irwin D. Simon, Aphria’s Chairman and CEO, will Lead the New Tilray and Has Appointed New Executive Leadership Team; New Members of the Board of Directors Also Appointed
New Tilray Poised to Transform the Global Cannabis Industry as a Consumer Packaged Goods Powerhouse with a Diversified Portfolio of Leading Brands
Renewed Financial Strength to Drive Accelerated Growth Strategy and Sustained Profitability
Tilray’s Shares Will Continue Trading on the NASDAQ Under Symbol “TLRY”; Starting May 5, 2021, Tilray’s Shares Will Commence Trading on the Toronto Stock Exchange Under Symbol “TLRY”
NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--May 3, 2021-- Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new era in the global cannabis industry. The combined company, which will operate as Tilray
NOTE: this 'NEW' Tilray was not operating in 2018.
The OLD Tilray stockprice skyrocketed when USA DEA & FDA gave Tilray permission to import medical cannabis into the USA.
Canadian marijuana producer Tilray posts second-best day ever after approval to import pot to US for medical study
PUBLISHED TUE, SEP 18 20189:04 AM EDTUPDATED WED, OCT 10 20188:33 AM EDT
https://www.cnbc.com/2018/09/18/tilray-shares-pop-after-us-clears-pot-importing-for-medical-study.html
Unfortuneately there are small minded fellows posting twisted BS to hurt TILRAY